Healthcare >> CEO Interviews >> October 26, 2004

Taffy Williams – Imcor Pharmaceuticals Co (icph)

TAFFY J. WILLIAMS is President and Chief Executive Officer of IMCOR Pharmaceutical Co. (formerly Photogen Technologies Inc.). Dr. Williams was President of InKine Pharmaceutical Company (formerly Panax Pharmaceutical Company). Prior to that, he was President, CEO and Chairman of Panax Pharmaceutical Company. In addition to executive management skills, the ability to grow companies and new business development experience, Dr. Williams is the author of eight patents, one invention registration, nine patent applications and 53 published articles. He also has been the recipient of several prestigious awards, including a postdoctoral fellowship from the National Institutes of Health, 'Most Significant Scientific Publication' awards from the Naval Medical Research Institute in 1985 and 1986, and the Civil Service Special Achievement Award for restructuring research activities in 1986. Dr. Williams holds a Bachelor's degree in Chemistry from the University of Notre Dame, a PhD in Biochemistry from the University of South Carolina, and he did postdoctoral training at the University of South Carolina and the University of Michigan. Profile
TWST: Give us a brief history of IMCOR and an overview of your products.

Dr. Williams: IMCOR Pharmaceutical Co. is a new name for the company

which was formerly called Photogen Technologies,